These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4016034)

  • 41. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
    Westhoff C; Osborne LM; Schafer JE; Morroni C
    Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormonal factors and the laboratory detection of Chlamydia trachomatis in women: implications for screening?
    Crowley T; Horner P; Hughes A; Berry J; Paul I; Caul O
    Int J STD AIDS; 1997 Jan; 8(1):25-31. PubMed ID: 9043977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Instructions for combined pill users.
    Reese M; Hatcher RA
    Contracept Technol Update; 1985 Jan; 6(1):19-20. PubMed ID: 12279914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
    Hauksson A; Akerlund M; Forsling ML; Kindahl H
    J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural changes in human cervical mucus.
    Pal T; Bhattacharyya AK
    Indian J Med Res; 1989 Feb; 90():44-50. PubMed ID: 2722215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
    Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
    Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extended cycle combined hormonal contraception.
    Steinauer J; Autry AM
    Obstet Gynecol Clin North Am; 2007 Mar; 34(1):43-55, viii. PubMed ID: 17472864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
    Cawello W; Rosenkranz B; Schmid B; Wierich W
    Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
    Petta CA; Faúndes A; Dunson TR; Ramos M; DeLucio M; Faúndes D; Bahamondes L
    Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO; op ten Berg MT; Coelingh Bennink HJ
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A model to detect interactions between roxithromycin and oral contraceptives.
    Meyer B; Müller F; Wessels P; Maree J
    Clin Pharmacol Ther; 1990 Jun; 47(6):671-4. PubMed ID: 2113449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and the vaginal route: an international multicenter clinical trial.
    Coutinho EM; Mascarenhas I; de Acosta OM; Flores JG; Gu ZP; Ladipo OA; Adekunle AO; Otolorin EO; Shaaban MM; Abul Oyoon M
    Clin Pharmacol Ther; 1993 Nov; 54(5):540-5. PubMed ID: 8222497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why Stop Now? Extended and Continuous Regimens of Combined Hormonal Contraceptive Methods.
    Benson LS; Micks EA
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):669-81. PubMed ID: 26598308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in thrombin-stimulated platelet malondialdehyde production during the menstrual cycle.
    Tindall H; Zuzel M; Paton RC; McNicol GP
    J Clin Pathol; 1981 Jun; 34(6):595-8. PubMed ID: 7251901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of low-dose oral contraceptives on female whole saliva.
    Laine M; Pienihäkkinen K; Ojanotko-Harri A; Tenovuo J
    Arch Oral Biol; 1991; 36(7):549-52. PubMed ID: 1837983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.